MedTrace Logo

Hemodynamic Monitoring in Obstetrics

NCT03755271 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 148

Last updated 2018-11-27

No results posted yet for this study

Summary

Spinal anesthesia has long been considered the first choice technique in caesarean section, but although it is a reliable and safe procedure, it is in some cases associated with undesirable effects. Maternal hypotension after sub-arachnoid anesthesia is a reduction in systolic blood pressure below 100 mmHg or a decrease of 20% compared to baseline values. According to some authors, maternal hypotension occurs up to 80% in women undergoing caesarean section after spinal anesthesia. In order to reduce the incidence of maternal hypotension, some measures can be taken:

* a reduction of aorto-caval compression by manual displacement of the uterus on the left;
* hemodynamic monitoring;
* administration of fluids;
* optimization of the dosage of the local anesthetic;
* use of vasopressors.

The main objective of the study is to investigate, through the use of a continuous non-invasive hemodynamic monitoring system (Clearsight® - Edwards Lifesciences), the incidence of hypotension in pregnant women at risk undergoing spinal anesthesia due to elective cesarean section.

Conditions

Sponsors & Collaborators

  • Marinella Astuto

    collaborator UNKNOWN

  • Carmelo Minardi

    collaborator UNKNOWN

  • Mirko Mineri

    collaborator UNKNOWN

  • Francesco Vasile

    collaborator UNKNOWN

  • Gaetano Joseph Palumbo

    collaborator UNKNOWN

  • University of Catania

    lead OTHER

Principal Investigators

  • Paolo Murabito, MD · University of Catania

  • Marinella Astuto, MD · University of Catania

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-02
Primary Completion
2018-07-20
Completion
2018-07-20

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03755271 on ClinicalTrials.gov